Semax
Janoshik
Batch SEM-CA-26A-01
Semax
ACTH-Derived Research Peptide
Semax is a synthetic peptide studied in laboratory settings for its involvement in neurotrophic signaling and cognitive-related pathways. Research commonly explores its interaction with regulatory mechanisms linked to neuronal communication, receptor activity, and overall central nervous system function in controlled experimental models.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) with structural modification to enhance stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.
In scientific literature, Semax is studied in models examining neuroendocrine signaling frameworks, peptide-mediated receptor interaction systems, and downstream regulatory mechanisms under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Semax is a modified ACTH fragment evaluated in research focused on neuropeptide signaling and central nervous system pathway interaction. Experimental studies examine its interaction with receptor-mediated signaling frameworks and peptide regulatory systems within controlled laboratory environments.
Research publications have explored its signaling characteristics and pathway-level interaction models under structured experimental conditions.
Semax was developed through investigations into synthetic derivatives of ACTH fragments designed to modify stability and signaling properties. Research expanded into neuropeptide pathway studies and central signaling system frameworks.
Subsequent publications documented its receptor interaction profile and regulatory signaling behavior in laboratory research models.
Laboratory investigations into Semax have focused on neuropeptide signaling models and receptor-mediated pathway interaction systems. Research frameworks evaluate peptide stability, central signaling dynamics, and downstream regulatory mechanisms under controlled in vitro and preclinical conditions.
0 of the 4 areas below are addressed directly by a paper cited on this page.
Neuropeptide signaling pathway models
No paper is cited on this page for Semax, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
ACTH fragment research frameworks
No paper is cited on this page for Semax, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
Central signaling system investigations
No paper is cited on this page for Semax, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
Receptor-mediated regulatory mechanism studies
No paper is cited on this page for Semax, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No primary literature is cited on this page for Semax. Where a compound has little or no indexed research behind it, saying so is more useful than presenting a thin record as a full one.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Semax, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Semax is also referred to as semax.
Semax is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under neuropeptide signaling pathway models, ACTH fragment research frameworks and central signaling system investigations.
No primary literature is cited on this page for Semax, because none suitable for citation was identified. That is the finding, not an omission: where a compound has no indexed published research behind it, no claim about what it does in any system is supported — including the framing above. It is supplied strictly as a research material for laboratory use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Semax is per lot, not per product. The current 10mg lot SEM-CA-26A-01 returned 99.566% purity, 11.69 mg measured, 116.9% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
Purity is half the number. It states what fraction of the material in the vial is Semax; it says nothing about how much material is in the vial, and a short-filled vial can return a purity result that is entirely accurate. The figure that answers the second question is measured mass against expected content — for Semax, this lot measured 116.9% of its labelled 10 mg. Both numbers are published for every lot, whichever way they fall.
The lot code printed on the vial matches the code on the certificate for Semax. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Semax in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
Semax is supplied as lyophilized powder. In the dry state the material is comparatively stable, which is why it ships at ambient temperature without a cold chain; once reconstituted it is a peptide in solution and the handling constraints tighten considerably. At 7 residues it is short enough to be produced by solid-phase synthesis, and the published sequence on this page is what an identity assay is checked against.
Repeated freeze-thaw cycling is the handling error most likely to degrade material of this class, because each cycle concentrates solutes at the ice boundary. Where a protocol calls for the same vial across multiple sessions, the published literature generally describes aliquoting after reconstitution rather than re-freezing the whole volume.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (10mg / Single Vial, 10mg / 5-Pack, 10mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized Semax. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99